1. A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture;Lewis;Dev Biol,2001
2. CBER Draft Guidance: Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases;FDA,2006
3. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production;Griffiths,1999
4. Risk of neoplastic transformation from cellular DNA: calculations using the oncogene model;Petricciani;Dev Biol Stand,1987
5. DNA, dragons and saity;Petricianni;Biologicals,1995